CompletedPHASE2, PHASE3NCT03829917

Oral Miltefosine Plus Topical Paromomycin In American Cutaneous Leishmaniasis

Studying Leishmaniasis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fundacion Nacional de Dermatologia
Principal Investigator
JAIME SOTO, MD
Fundación Nacional de Dermatología
Intervention
Miltefosine and Paromomycin(drug)
Enrollment
120 target
Eligibility
12 years · All sexes
Timeline
2019 – 2020

Study locations (1)

Collaborators

Hospital Dermatológico de Jorochito · Ministerio de Salud de Bolivia, Programa Nacional de Leishmaniasis · Alfred Berman Foundation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03829917 on ClinicalTrials.gov

Other trials for Leishmaniasis

Additional recruiting or active studies for the same condition.

See all trials for Leishmaniasis →

← Back to all trials